Pharmaceutical applications of β-cyclodextrin

Pharmaceutical Technology

Volumn 23, Issue 12, 1999, Pages 40-50

  Loftsson, Thorsteinn ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002630922     PISSN: 01478087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. A. Villiers, "Sur la Fermentation de la Fécule par l'Action du Ferment Butyrique," C.R. Hebd. Séances Acad. Sci. Paris 112,536-538 (1891).
2. T. Endo et al., "Isolation, Purification and Characterization of Cyclomaltooctadecaose (ν-Cyclodextrin), Cyclomaltononadecaose (ξ-Cyclodextrin, Cyclomaltoeicosaose (o-Cyclodextrin), and Cyclomaltoheneicosaose (π-Cyclodextrin)," Chem. Pharm. Bull. 46,1840-1843(1998).
3. L. Szente and J. Szejtli, "Highly Soluble Cyclodextrin Derivatives: Chemistry, Properties, and Trends in Development," Adv. Drug Deliv. Rev. 36, 17-28 (1999).
4. K.H. Fromming and J. Szejtli, Cyclodextrins in Pharmacy, Vol 5, J.E.D. Davies, Ed., (Kluwer Academic Publishers, The Netherlands, 1994).
5. T. Loftsson and M.E. Brewster, "Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization," J. Phann. Sci. 85, 1017-1025 (1996).
6. R.A. Rajewski and V.J. Stella, "Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery," J. Phann. Sci. 85, 1142-1168(1996).
7. T. Irie and K. Uekama, "Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation," J. Phann. Sci. 86, 147-162 (1997).
8. V.J. Stella and R.A. Rajewski, "Cyclodextrins: Their Future in Drug Formulation and Delivery," Pharm. Res. 14, 556-567 (1997).
9. D.O. Thompson, "Cyclodextrins-Enabling Excipients: Their Present and Future Use in Pharmaceuticals," CriJ. Rev. Tlier. Drug Carrier Syst. 14, 1-104(1997).
10. D. Duchêne and D. Wouessidjewe, "Pharmaceutical and Medical Applications of Cyclodextrins," in Polysaccharides in Medical Applications, S. Dumitriu, Ed. (Marcel Dekker, New York, 1996), pp. 575-602.
11. K. Uekama, Ed., Cyclodextrins in Drug Delivery. Advanced Drug Delivery Reviews, Vol. 36 (1) (Elsevier Science, Amsterdam, The Netherlands, 1999).
12. V.T. D'Souza and K.B. Lipkowitz, Eds., Cyclodextrins. Chemical Reviews, Vol. 98 (5) (American Chemical Society, Washington, DC, 1998).
13. J. Szejtli, Cyclodextrin Technology (Kluwer Academic Publishers, Dordrecht, The Netherlands, 1988).
14. V.J. Stella et al., "Mechanism of Drug Release from Cyclodextrin Complexes," Adv. Drug Deliv. Rev. 36,3-16 (1999).
15. F. Hirayama and K. Uekama, "Cyclodextrin-Based Controlled Drug Release Systems," Arfu Drug Deliv. Rev. 36,125-141 (1999).
16. T. Loftsson and H. Fridriksdöttir, "The Effect of Water-Soluble Polymers on the Aqueous Solubility and Complexing Abilities of β-Cyclodextrin," Int. J. Phann. 163,115-121(1998).
17. T. Loftsson and M.E. Brewster, "Cyclodextrins as Pharmaceutical Excipients," Phann. Technol. Em. 9 (5), 26-33 (1997).
18. M.E. Bellringer et al., "β-Cyclodextrin: 52-Week Toxicity Studies in the Rat and Dog," Food Chem. Toxicol. 33,367-376 (1995).
19. K. Toyoda et al., "Carcinogenicity Study of β-Cyclodextrin in F344 Rats," Food Chem. Toxicol. 53, 331-336 (1997).
20. W.L. Song, Q.G. Huang, and L.S. Wang, "β-Cyclodextrin (β-CD) Influence on the Biotoxicities of Substituted Benzene Compounds and Pesticide Intermediates," Chemosphere 38,693-698 (1999).
21. T. Loftsson, "Increasing the Cyclodextrin Complexation of Drugs and Drug Bioavailability through Addition of WaterSoluble Polymers," Pharmazie 53, 733-740 (1998).
22. A.R. Hedges, "Industrial Applications of Cyclodextrins," Chem. Rev. 98, 2035-2044 (1998).
23. F. Hirayama and K. Uekama, "Methods of Investigating and Preparing Inclusion Compounds," in Cyclodextrins and their Industrial Uses, D. Duchêne, Ed. (Editions de Santé, Paris, 1987), pp 131-172.
24. P. Jarho et al., "Hydroxypropyl-βCyclodextrin and Its Combination with Hydroxypropyl Methylcellulose Increases Aqueous Solubility of Δ(9)-Tetrahydrocannabinol," Life Sci. 63, 381-384(1998).
25. J. Savolainen et al., "Coadministration of a Water-Soluble Polymer Increases the Usefulness of Cyclodextrins in Solid Dosage Forms," Pharm. Res. 15, 1696-1701 (1998).
26. Y. Nakai et al., "New Methods for Preparing Cyclodextrin Inclusion Compounds. I. Heating in a Sealed Container," Client. Pharm. Bull. 35,4609-4615 (1987).
27. Y. Nakai et al., "New Methods for Preparing Cyclodextrin Inclusion Compounds. III. Preparation of Heptakis-(2,6-di-O-methyl)-β-Cyclodextrin-Benzoic Acid Inclusion Compound by Sealed Heating," Client. Pharm. Bull. 38, 1345-1348 (1990).
28. Y. Nakai et al., "New Methods for Preparing Inclusion Compounds. II. Effects of Heating Temperature, Water Content, and Drug Properties on the Inclusion Formation," Chem. Phann. Bull. 37,1055-1058 (1989).
29. T. Loftsson and J.H. Ölafsson, "Cyclodextrins: New Drug Delivery Systems in Dermatology," Int. J. Dermatol. 37, 241-246 (1998).
30. T. Loftsson and T. Järvinen, "Cyclodextrins in Ophthalmic Drug Delivery," Adv. Drug Deliv. Rev. 36,59-79(1999).
31. M. Masson et al., "Cyclodextrins as Permeation Enhancers: Some Theoretical Evaluations and In Vitro Testing," J. Controlled Release 59,107-118 (1999).
32. M. Addy, S. Jenkins, and R. Newcombe, "Toothpastes Containing 0.3% and 0.5% Triclosan. II. Effects of Single Brushings on Salivary Bacterial Counts," Am. J. Dent. 2,215-219 (1989).
33. D. Cummins and J.E. Creeth, "Delivery of Antiplaque Agents from Dentifrices, Gels, and Mouthwashes," J. Dent. Res. 71,1439-1449 (1992).
34. J. Szejtli, "Introduction and General Overview of Cyclodextrin Chemistry," Chem. Rev. 98,1743-1753 (1998).
35. European Pharmacopoeia (Council of Europe, Strasbourg, 3d ed., 1997). -
36. USP 23/NF 18 (United States Pharmacopeia! Convention, Inc., Rockville, MD, 1995).
37. R.A. Nash, "Cyclodextrins," in Handbook of Pharmaceutical Excipients, A. Wade and P.J. Weller, Eds. (Pharmaceutical Press & American Pharmaceutical Association, London, 1994), pp. 145-148.
38. Toxicological data BETA W7 (Wacker-Chemie GmbH, Munich, Germany, 1997).